Abstract
We are writing to comment on the paper ‘Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis’ by Shu et al. 1 Findings from the study suggest that genetically instrumented fasting insulin (FI) and 2-hour glucose (2hrGlu) levels were positively associated with breast cancer (BCa) risk, whereas genetically instrumented body mass index (BMI) and waist–hip ratio with adjustment of BMI (WHRadjBMI) were inversely associated with BCa risk.
Funding Information
  • Cancer Research UK
  • The Integrative Cancer Epidemiology Programme (C18281/A19169)
  • Wellcome Trust (202802/Z/16/Z)
  • MRC Integrative Epidemiology Unit (MC_UU_12013/3)
  • University of Bristol
  • NIHR
  • Biomedical Research Centre
  • BRC
  • Cancer Research UK Research (C18281, A20988)
  • MRC Integrative Epidemiology Unit
  • Medical Research Council (MC_UU_12013/5)

This publication has 8 references indexed in Scilit: